- Home
- PBYI vs TOUR Comparison
PBYI vs TOUR Comparison
Compare PBYI & TOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- TOUR
- Stock Information
- Founded
- PBYI 2010
- TOUR 2006
- Country
- PBYI United States
- TOUR China
- Employees
- PBYI N/A
- TOUR N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- TOUR Transportation Services
- Sector
- PBYI Health Care
- TOUR Consumer Discretionary
- Exchange
- PBYI Nasdaq
- TOUR Nasdaq
- Market Cap
- PBYI 145.3M
- TOUR 117.7M
- IPO Year
- PBYI N/A
- TOUR 2014
- Fundamental
- Price
- PBYI $2.91
- TOUR $1.04
- Analyst Decision
- PBYI Strong Buy
- TOUR
- Analyst Count
- PBYI 1
- TOUR 0
- Target Price
- PBYI $7.00
- TOUR N/A
- AVG Volume (30 Days)
- PBYI 288.9K
- TOUR 184.2K
- Earning Date
- PBYI 02-27-2025
- TOUR 03-12-2025
- Dividend Yield
- PBYI N/A
- TOUR N/A
- EPS Growth
- PBYI 492.79
- TOUR N/A
- EPS
- PBYI 0.47
- TOUR N/A
- Revenue
- PBYI $243,569,000.00
- TOUR $72,825,718.00
- Revenue This Year
- PBYI N/A
- TOUR $20.26
- Revenue Next Year
- PBYI N/A
- TOUR $15.73
- P/E Ratio
- PBYI $6.24
- TOUR N/A
- Revenue Growth
- PBYI 6.30
- TOUR 38.57
- 52 Week Low
- PBYI $2.23
- TOUR $0.59
- 52 Week High
- PBYI $7.15
- TOUR $1.76
- Technical
- Relative Strength Index (RSI)
- PBYI 48.76
- TOUR 55.93
- Support Level
- PBYI $2.69
- TOUR $0.97
- Resistance Level
- PBYI $2.98
- TOUR $1.07
- Average True Range (ATR)
- PBYI 0.12
- TOUR 0.04
- MACD
- PBYI 0.01
- TOUR 0.00
- Stochastic Oscillator
- PBYI 58.11
- TOUR 57.69
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About TOUR Tuniu Corporation
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. All the company's revenues are derived from within the People's Republic of China.